Community Oncology Alliance

What Community Oncology Alliance does

Community Oncology Alliance (COA) is a national 501(c)(6) nonprofit organization founded in 2002 and headquartered in Washington, D.C., dedicated solely to advocating for independent community oncology practices and the patients they serve. The organization serves two primary constituencies: independent community oncology practices (70+ members) that face hospital consolidation, reimbursement pressure, and regulatory burden, and corporate partners (80+ members) across biotechnology, pharmaceutical, genomics, drug delivery, and distribution. COA delivers value through five professional sub-brands (CAN, COPA, CPAN, Fellows Initiative, NCTA), nine standing committees covering policy, cellular therapy, payment reform, and AI, plus a portfolio of member-facing tools including COAnalyzer benchmarking software, a Policy Tracker, PBM & Insurer Abuse Tools, a Patient Satisfaction Survey, and the AI Playbook launched in June 2026.

The business model is membership-driven with two subscription tiers: practice membership (variable pricing by practice size) and corporate membership (tiered by company type and engagement level), both billed annually. Events and conferences are a third revenue stream, anchored by the Annual Community Oncology Conference (held April 28-29, 2026 in Orlando) and the invitation-only Payer Exchange Summit (September 14-15, 2026 in Tysons Corner). Distribution is primarily direct membership via the website and outreach at industry events, supported by a digital myCOA member portal providing 24/7 access to resources, tools, and event registration.

Beyond member services, COA operates as a sustained federal and state policy advocate, having filed five amicus briefs regarding the 340B Drug Pricing Program and PBM reform across four federal circuits, and securing inclusion of major PBM reforms in the $1.2T federal spending package signed in February 2025. The organization has also invested in clinical evidence generation, including a 2026 landmark study with Flatiron Health analyzing nearly 98,000 patient records, and operates an annual Hill Day convening nearly 100 advocates in Washington, D.C. for direct congressional engagement.

Name

Community Oncology Alliance

Legal name

Community Oncology Alliance

Website

https://communityoncology.org

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Community Oncology Alliance is a national nonprofit founded in 2002 that advocates for 70+ independent community oncology practices and 80+ corporate members through policy advocacy, professional initiatives, benchmarking tools, and annual conferences across the United States.

Ownership category

akta.pro rank

Product category

Oncology Association & Advocacy Services

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Association & Society Conference Management (Nonprofit, Professional Bodies) (THAHACAA)

akta.pro secondary industry

Medical Oncology (HLAKAFAB)

Keywords

• Oncology advocacy services
• Healthcare association membership
• Practice benchmarking software
• Oncology policy research
• Professional oncology education

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Practice Membership Fees: Entire practice membership with variable, discounted pricing based on practice size. New team members can be added throughout the year.
2. Corporate Membership Fees: Companies across biotechnology, pharmaceutical, genomic, drug delivery, distribution, and related fields support COA as corporate members to advance COA's education, advocacy, and special projects.
3. Events and Conferences: Revenue from the COA Annual Community Oncology Conference, Payer Exchange Summit, webinars, and member meetings.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Community Oncology Alliance is a national nonprofit membership organization that provides policy advocacy, practice support resources, and professional education to independent community oncology practices and industry partners. Its core offerings include benchmarking software (COAnalyzer), a policy tracking tool, PBM and insurer abuse resources, patient satisfaction surveys, an AI adoption playbook, and the Annual Community Oncology Conference, along with five professional initiatives (CAN, COPA, CPAN, Fellows Initiative, NCTA) and federal/state advocacy including amicus briefs and Hill Day convenings.

Product overview

The Community Oncology Alliance (COA) is a national nonprofit advocacy organization dedicated solely to strengthening independent community oncology. Rather than a unified software platform, COA offers a portfolio of member resources including COAnalyzer (benchmarking software), Policy Tracker, Patient Satisfaction Survey, PBM & Insurer Abuse Tools, and the AI Playbook. These tools support practice operations, policy tracking, and quality measurement. COA also runs professional initiatives (CAN, COPA, CPAN, Fellows Initiative, NCTA), organizes the Annual Community Oncology Conference and Payer Exchange Summit, and publishes studies, reports, and position statements on community oncology care delivery.

Differentiator

Problem solved

Functional benefit

Brands

• COA Administrators' Network (CAN): Professional initiative supporting COA administrators and practice managers
• Community Oncology Pharmacy Association (COPA)
• COA Advocacy Network (CPAN)
• COA Fellows Initiative
• National Cancer Treatment Alliance (NCTA)
• COA AI Playbook
• COAnalyzer

Products and services

• COAnalyzer (Benchmarking Software) Free benchmarking tool that allows community oncology practices to access real-time data on their performance and compare against peer practices, available to members through the myCOA portal.
• Policy Tracker Digital tool for tracking federal and state policy developments relevant to community oncology practices, accessible via the myCOA portal.
• Patient Satisfaction Survey Survey tool for measuring patient satisfaction in community oncology practices.
• PBM & Insurer Abuse Tools Resource suite to help member practices identify and address pharmacy benefit manager (PBM) and insurer abuses affecting community oncology.
• COA AI Playbook Strategic and operational framework for assessing and responsibly adopting artificial intelligence in independent community oncology practices.
• COA Administrators' Network (CAN) Professional initiative providing resources, networking, and monthly meetings for oncology practice administrators and practice managers.
• Community Oncology Pharmacy Association (COPA) Professional initiative focused on pharmacy-related issues, best practices, and monthly meetings for community oncology pharmacy professionals.
• COA Patient Advocacy Network (CPAN) Patient advocacy network supporting community oncology patients, caregivers, and survivors through education, engagement, and advocacy chapters.
• COA Fellows Initiative Initiative supporting hematology/oncology fellows exploring community oncology careers through programming and the Fellows Board.
• National Cancer Treatment Alliance (NCTA) Alliance supporting national cancer treatment coordination in community oncology settings.
• Annual Community Oncology Conference Annual flagship conference bringing together oncology professionals, industry partners, and patient advocates for education, networking, and advocacy; recent themes center on AI, cellular therapy, and policy.
• Payer Exchange Summit By-invitation annual summit connecting community oncology practices with payers to discuss payment reform and innovation.
• COATV Educational video content platform providing professional education for community oncology practitioners.
• COA Practice Membership Annual subscription membership for entire oncology practices, with variable, size-based discounted pricing and access to COA tools, initiatives, conferences, and advocacy.
• COA Corporate Membership Annual tiered corporate membership for biotechnology, pharmaceutical, genomic, drug delivery, distribution, and related companies supporting COA's education, advocacy, and special projects.

Quantifiable outcome

• Patients with metastatic breast cancer treated in community oncology settings experienced median survival 8 months longer than SEER benchmarks
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Flatiron HealthcoreStrategic or Co-development Partner · 28 April 2026COA and Flatiron Health conducted a landmark study analyzing data from nearly 98,000 patients in the Flatiron Health Research Network, finding that patients with metastatic breast cancer and NSCLC treated in community oncology settings experienced longer survival compared to SEER benchmarks. This represents the first phase of a multiyear collaboration.
• Florida Cancer Specialists & Research InstitutecoreStrategic or Co-development PartnerFCS senior leaders are presenting at COA 2026 Conference showcasing innovative solutions for community-based cancer care, including sessions on cell therapy expansion, clinical trial access, AI tools, and quality metrics. FCS has over 40 years of experience and 180+ active clinical trials.
• American Oncology NetworkcoreStrategic or Co-development PartnerAON participated in 11 speaking sessions at COA 2026 on topics including CAR T therapies, payer contracting, patient advocacy, clinical trials, radiopharmaceuticals, and careers in community oncology. AON also exhibited at booth 207.

Scale indicators4 records

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• American Association for Cancer Research (AACR): Largest cancer research organization, with overlapping membership among oncology professionals and parallel advocacy on federal research funding. AACR is a broader incumbent focused on research rather than community practice delivery.
• American Society of Clinical Oncology (ASCO): Largest U.S. professional society for oncologists, with overlapping physician membership, policy advocacy, and practice resources. ASCO is a broader incumbent that competes with COA on education, clinical guidelines, and policy voice.
• National Comprehensive Cancer Network (NCCN): Alliance of leading academic cancer centers that sets oncology treatment guidelines and shapes payer coverage policy. NCCN overlaps with COA on policy influence and member education but is anchored to academic centers rather than community practices.

Direct peers

• AMGA (American Medical Group Association): Trade association for multispecialty medical groups and integrated systems of care, with similar advocacy, benchmarking, and educational offerings. Overlaps with COA on policy advocacy for provider economics and on benchmarking products like COAnalyzer.
• Medical Group Management Association (MGMA): National membership association for medical group practice administrators. MGMA is the most relevant structural analog — analogous practice-management tools, benchmarking data products, and policy advocacy — but serves medical groups broadly rather than oncology specifically.
• Oncology Nursing Society: Professional society for oncology nurses with a similar association model (membership, conferences, advocacy, education) and overlapping member base inside community oncology practices.
• Hematology/Oncology Pharmacy Association (HOPA): Professional association for hematology/oncology pharmacists, directly overlapping with COPA (COA's pharmacy subsidiary). HOPA is a strong peer on the pharmacy-policy and education dimensions of COA's work.
• National Community Pharmacists Association (NCPA): Membership association for independent community pharmacies with a comparable advocacy-plus-tools model (independent provider economics, PBM reform, benchmarking). Strong peer for COA's pharmacy-distribution and PBM reform agenda via COPA.
• Association of Cancer Care Centers (ACCC): National membership organization serving oncology practices and cancer programs; the most direct peer to COA, operating a similar advocacy-plus-education model for community cancer care. Betsy Spruill, COA's Director of Industry Relations (Oct 2025), joined COA from ACCC, underscoring how directly comparable the two organizations are.

Others

• American Cancer Society: National nonprofit focused on patient advocacy, research funding, and access to care. Comparable to COA's CPAN patient-advocacy arm and shares Hill Day-style government engagement, though ACS is patient-funded rather than provider-funded.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/coacancer
• Xx.com/OncologyCOA
• Facebookfacebook.com/CommunityOncologyAlliance

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Community Oncology Alliance